Y Sasaki

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.

M Taniwaki, M. Taniwaki, Y. Ohashi, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Indirect‐response model for the time course of leukopenia with anticancer drugs

N. Saijo, K. Itoh, Y. Sasaki, 1998, Clinical pharmacology and therapeutics.